Moreover, brain-invading CD8+ T lymphocytes showed an increased expression of CD69 surface marker, suggesting that these cells may acquire a TRM phenotype once migrated into the brain (16), similarly to what has been previously described in MS (12). The gene discussed is CD8A; the disease is myeloid sarcoma.